A growing number of FDA-approved innovators and biosimilars are being manufactured at China-based facilities as biopharma takes interest in the…
Read More

A growing number of FDA-approved innovators and biosimilars are being manufactured at China-based facilities as biopharma takes interest in the…
Read More
Physicists at the University of California, Santa Barbara (UCSB), working in collaboration with the international Compact Muon Solenoid (CMS) experiment…
Read More
The Physiology of Choice: Beyond the Brain For decades, neuroscientists focused almost exclusively on the brain as the central command…
Read More
A recent poster presentation at Psych Congress Elevate by Johnson & Johnson has placed esketamine nasal spray, marketed as Spravato,…
Read More
More than six decades after Calvin Stevens first synthesized ketamine at Parke-Davis in 1962 while diligently searching for a safer…
Read More
The National Aeronautics and Space Administration has successfully restored and enhanced its Cold Atom Lab (CAL) aboard the International Space…
Read More
More than six decades after Calvin Stevens first synthesized ketamine at Parke-Davis in a quest for a safer anesthetic, the…
Read More
Johnson & Johnson is intensifying its efforts to expand the market footprint of Spravato (esketamine) for treatment-resistant depression (TRD), leveraging…
Read More
More than six decades after Calvin Stevens first synthesized ketamine at Parke-Davis while searching for a safer anesthetic, the molecule…
Read More
A collaborative research effort between the University of Vienna and the University of Duisburg-Essen has successfully demonstrated quantum interference in…
Read More